Alaunos Therapeutics (NASDAQ:TCRT) just reported results for the fourth quarter of 2023.
- Alaunos Therapeutics reported earnings per share of -55 cents. This was below the analyst estimate for EPS of -45 cents.
- The company reported revenue of $1,000.
Source: iQoncept / Shutterstock
Alaunos Therapeutics (NASDAQ:TCRT) just reported results for the fourth quarter of 2023.
Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/04/tcrt-stock-earnings-alaunos-therapeutics-for-q4-of-2023/.
©2025 InvestorPlace Media, LLC